{
    "clinical_study": {
        "@rank": "25099", 
        "arm_group": [
            {
                "arm_group_label": "Acetaminophen ER", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Single dose (2 tablets) Acetaminophen ER 750 mg matching placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate the efficacy and safety of acetaminophen ER 1500 mg\n      (two 750 mg tablets) over 10 to 12 hours in the dental pain model following third molar\n      extraction(s) and to evaluate the pharmacokinetics of acetaminophen ER 1500 mg (two 750 mg\n      tablets) in a sub-group of subjects."
        }, 
        "brief_title": "Study of Long-Acting Acetaminophen in Postoperative Dental Pain", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Dental Pain", 
        "condition_browse": {
            "mesh_term": "Toothache"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Must be at least 18 and less than 46 years of age\n\n          -  Must weigh at least 100 lbs with a body mass index of at least 18 and less than 30\n\n          -  Scheduled to undergo surgical extraction of one impacted third molar from the lower\n             jaw.  The third molar from the upper jaw from the same side may also be removed.\n\n          -  Experiencing moderate to severe pain after extraction of third molars.\n\n        Exclusion Criteria:\n\n          -  Cannot be allergic to acetaminophen (Tylenol) or any non-steroidal anti-inflammatory\n             drugs (e.g., Motrin, Advil, Aleve, Naproxen).\n\n          -  Cannot be pregnant (or planning to be pregnant) or nursing a baby\n\n          -  Unable to swallow whole large tablets or caplets.\n\n          -  Cannot have any other medical conditions that the investigator feels may compromise\n             your safety or the study results."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01960114", 
            "org_study_id": "AERPAI2001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Acetaminophen ER", 
                "description": "Single dose (2 tablets) Acetaminophen ER 750 mg", 
                "intervention_name": "Acetaminophen ER", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Single dose (2 tablets) Acetaminophen ER 750 mg matching placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Acetaminophen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Acetaminophen", 
            "Paracetamol Analgesics", 
            "Analgesics", 
            "Non-Narcotic Pain", 
            "Postoperative Pain", 
            "Antipyretics Dental Surgery", 
            "Third molar extraction"
        ], 
        "lastchanged_date": "April 16, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Salt Lake City", 
                    "country": "United States", 
                    "state": "Utah", 
                    "zip": "84124"
                }, 
                "name": "Jean Brown Research"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Efficacy, Safety, and Pharmacokinetics Study of Extended-Release (ER) Acetaminophen in Postoperative Dental Pain", 
        "overall_official": {
            "affiliation": "McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.", 
            "last_name": "McNeil Study Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Time weighted sum of pain intensity difference scores from baseline over 10 hours.  Pain intensity was evaluated using a 0-10 numerical rating scale (NRS) where 0 = no pain and 10 = very severe pain.", 
            "measure": "Time weighted sum of Pain Intensity Difference over 10 hours (SPID 0-10)", 
            "safety_issue": "No", 
            "time_frame": "10 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01960114"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Minutes until confirmed first perceptible pain relief are achieved.  Stopwatch is started after the subject takes the study medication.  The subject is instructed to stop the stopwatch when they first began to feel any pain relief.  The first perceptible pain relief is confirmed if the subject also stopped the second stopwatch indicating meaningful pain relief.", 
                "measure": "Time to confirmed first perceptible pain relief", 
                "safety_issue": "No", 
                "time_frame": "Within 12 hours"
            }, 
            {
                "description": "Minutes until meaningful pain relief are achieved.  Stopwatch is started after the subject takes the study medication.  The subjects are instructed to stop the stopwatch when the relief from the starting pain is meaningful to them.", 
                "measure": "Time to meaningful pain relief", 
                "safety_issue": "No", 
                "time_frame": "Within 12 hours"
            }, 
            {
                "description": "Minutes until rescue medication is given", 
                "measure": "Duration of pain relief", 
                "safety_issue": "No", 
                "time_frame": "Within 12 hours"
            }, 
            {
                "description": "Patient assessment of the pain medication - Number of subjects rating the medication they received as a pain reliever on a score of 0-4, where 0=poor, 1=fair, 2=good, 3=very good, 4=excellent.", 
                "measure": "Patient Global Evaluation", 
                "safety_issue": "No", 
                "time_frame": "12 hours"
            }
        ], 
        "source": "Johnson & Johnson Consumer and Personal Products Worldwide", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Johnson & Johnson Consumer and Personal Products Worldwide", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}